Viewing nowDiarrhea 2mg Tablets (Glimepiride)
Glimepiride 2mg
Tablet · Prescription medication
Kwangdong Pharmaceutical Co., Ltd.

MFDS item code 201306526 · Approved 2013.03.29 · Insurance code 641805500
Improvement of glycemic control in type 2 diabetes mellitus
This medication is used to help control blood sugar levels in patients with type 2 diabetes along with diet and exercise. It can be used alone or in combination with other oral hypoglycemic agents or insulin when blood sugar control is difficult. Furthermore, it can be used with metformin when the effect of monotherapy with sulfonylureas or metformin is insufficient to support blood sugar management. This medication helps effectively improve blood sugar levels.
Adjust the dose individually for each patient. Swallow without chewing with at least 1/2 cup of water. This medicine is administered orally once daily. Take this medicine before breakfast or immediately before the first meal. It is very important not to skip a meal after taking this medicine. 1. Monotherapy 1) Initial dose and dose titration For patients who have not previously received medication, start treatment with 1 mg of glimepiride once daily. If necessary, increase the dose by 1 mg at intervals of 1 ~ 2 weeks. In general, doses above 4 mg provide little additional effect, although some patients have achieved better metabolic control by increasing the dose to 6 mg (or 8 mg). If treatment with 4 mg per day is unsuccessful, first consider switching to insulin therapy; otherwise, consider combination therapy with insulin or another oral antidiabetic medicine. 2) Subsequent dose adjustment As diabetes control improves during treatment, the requirement for this medicine may decrease. Therefore, dose reduction or discontinuation of this medicine may be necessary to avoid hypoglycemia. Dose adjustment should also be considered if weight loss, lifestyle changes, or other factors that may increase the risk of hypoglycemia or hyperglycemia occur. 3) Switching from another oral hypoglycemic agent to this medicine There is no exact dose equivalence between this medicine and other oral hypoglycemic agents. When switching from another oral hypoglycemic agent to this medicine, it is advisable to follow the method described under Initial dose. That is, start with 1 mg once daily and adjust the dose at 1 ~ 2-week intervals. Consider the potency and duration of action of the previous medicine. 4) Dose monitoring During treatment with this medicine, blood glucose and/or urine glucose levels should be measured regularly, and regular measurement of glycosylated hemoglobin (HbA1c) is also recommended. In general, hypoglycemia can be promptly controlled by consuming sugar. Hypoglycemia may recur despite successful initial management during treatment with a sulfonylurea. Therefore, monitor patients closely. Severe hypoglycemia requires immediate medical treatment and follow-up, and hospitalization may sometimes be necessary. 2. Combination therapy 1) Combination therapy with insulin Combination therapy with this medicine and insulin is used in patients with secondary failure and when fasting blood glucose (FBG) exceeds 150 mg/dL. Administer 8 mg of this medicine once daily with the first meal, and start insulin at a low dose, increasing it at approximately weekly intervals according to fasting blood glucose measurements. Once stabilized, monitor capillary blood glucose daily whenever possible. Adjust the insulin dose periodically while measuring blood glucose and glycosylated hemoglobin. 2) Combination therapy with metformin If the patient does not respond adequately to the maximum dose of this medicine, addition of metformin may be considered. Published clinical information is available on combination therapy of metformin with other sulfonylureas, such as glibenclamide, glipizide, chlorpropamide, and tolbutamide. When this medicine is used in combination with metformin, the desired blood glucose level may be achieved by adjusting the dose of each medicine. However, efforts should be made to determine the minimum effective dose of each medicine for blood glucose control. There is a risk of hypoglycemia with concomitant administration of this medicine and metformin, and the risk may increase. Appropriate caution should be exercised.
This medication should not be used in patients with insulin-dependent diabetes, diabetic ketoacidosis, or those in a comatose state. Additionally, individuals allergic to this medication or its components, sulfonylureas, or sulfonamides should avoid taking it. There is no experience of use in patients with severe liver or kidney dysfunction, and switching to insulin therapy is recommended for these patients. It is also safe not to use this medication in pregnant or potentially pregnant women, as well as breastfeeding women. In patients with severe infections, pre- or post-surgery, or severe trauma, insulin therapy is recommended, and caution should be exercised in cases of gastrointestinal disorders due to the risk of hypoglycemia. This medication contains lactose, so patients with lactose intolerance or related genetic diseases should not take it. There is a high risk of hypoglycemia during the first week of treatment, so blood sugar should be monitored carefully. Special care should be taken especially for the elderly, those with poor nutritional status or irregular eating habits, those whose physical activity does not match their food intake, those who frequently consume alcohol, and those with weakened liver or kidney function. Additionally, the risk of hypoglycemia may increase in those with endocrine diseases or those taking other medications. This medication contains the dye Tartrazine (Yellow No. 5), so those allergic to this component should use it carefully. Symptoms of hypoglycemia may include headache, severe hunger, nausea, fatigue, anxiety, confusion, dizziness, etc., so if these symptoms occur, sugar should be consumed immediately. Various side effects such as blurred vision, gastrointestinal disturbances, liver dysfunction, blood dyscrasias, and allergic reactions may occur, so it is necessary to consult a doctor if abnormal symptoms appear. It is important to combine diet and exercise while taking this medication and be prepared to consume sugar immediately in case of hypoglycemia. When receiving treatment at other hospitals or pharmacies, it is essential to inform them that you are taking this medication, and in stressful situations or during surgery, switching to insulin therapy may be necessary. This medication is excreted through the kidneys, so dose adjustments may be needed for the elderly. In case of overdose, severe hypoglycemia may occur, necessitating immediate treatment at a hospital. When storing, keep it out of reach of children and store it in the original container.
Hypoglycemia, headache, severe hunger, nausea, vomiting, fatigue, sleep, sleep disorders, anxiety, aggression, decreased concentration, decreased agility or activity, depression, confusion, speech abnormalities, aphasia, visual impairment, tremors, incomplete paralysis, sensory disturbances, dizziness, weakness, loss of self-control, transient mental confusion, brain convulsions, drowsiness, loss of consciousness, coma, shallow breathing, bradycardia, sweating, cold and damp skin, tachycardia, hypertension, palpitations, angina, deep vein issues, blurred vision, fullness or pressure in the upper abdomen, abdominal pain, diarrhea, increased liver enzymes, liver dysfunction, bile secretion disorder, jaundice, hepatitis, thrombocytopenia, leukopenia, hemolytic anemia, erythrocytopenia, granulocytopenia, agranulocytosis, pancytopenia, allergy, itching, urticaria, rash, respiratory distress, hypotension, shock, anaphylaxis, angioedema, Stevens-Johnson syndrome, allergic vasculitis, cutaneous phototoxicity, reduced serum sodium concentration, taste disturbances, hair loss, weight gain, dizziness, liver dysfunction, abdominal pain, arthralgia, dyspepsia, facial edema, erectile dysfunction, facial flushing, gastritis
Not everyone experiences these, and they can vary from person to person.
This medication must be stored in a tightly closed container to avoid exposure to air or moisture. It is also important to store the medication at room temperature, which should not be too hot or too cold, specifically between 1°C and 30°C.
Green oblong tablets
30 tablets/bottle, 300 tablets/bottle
Even with the same ingredient, strength, dosage form and how it is taken can differ.
Viewing nowGlimepiride 2mg
Tablet · Prescription medication
Kwangdong Pharmaceutical Co., Ltd.

Glimepiride 1mg
Tablet · Prescription medication
Handok Co., Ltd.

Glimepiride 2mg
Tablet · Prescription medication
Handok Co., Ltd.

Glimepiride 4mg
Tablet · Prescription medication
(Hanmi Pharmaceutical Co., Ltd.)

Glimepiride 2mg
Tablet · Prescription medication
Seoul Pharmaceutical Co., Ltd.

Glimepiride 2mg
Tablet · Prescription medication
Shinpoong Pharmaceutical Co., Ltd.

Glimepiride 2mg
Tablet · Prescription medication
Jongkundang Co., Ltd.

Glimepiride 2mg
Tablet · Prescription medication
IYun Pharmaceuticals Co., Ltd.
Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.
No questions yet.
For anything that needs medical judgment, consult a doctor or pharmacist.
This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.